Eric Tai1, Natasha Buchanan2, Lauren Westervelt3, Dena Elimam3, Silvana Lawvere4. 1. Centers for Disease Control and Prevention, Atlanta, Georgia; etai@cdc.gov. 2. Centers for Disease Control and Prevention, Atlanta, Georgia; 3. SciMetrika LLC, Research Triangle Park, North Carolina; and. 4. Department of Biostatistics, School of Public Health, University of North Carolina, Chapel Hill, North Carolina.
Abstract
BACKGROUND: There has been an overall improvement in survival rates for persons with cancer over the past 35 years. However, these gains are less prevalent among adolescents with cancer aged 15 to 19 years, which may be due to lower clinical trial enrollment among adolescents with cancer. METHODS: We conducted a literature review to assess current research regarding clinical trial enrollment and subsequent outcomes among adolescents with cancer. The search included English-language publications that reported original data from January 1985 to October 2011. RESULTS: The search identified 539 records. Of these 539 records, there were 30 relevant original research articles. Multiple studies reported that adolescents with cancer are enrolled in clinical trials at lower rates compared with younger children and older adults. Treatment setting, physician type, and institution type may all be factors in the low enrollment rate among adolescents. Few data focused solely on adolescents, with many studies combining adolescents with young adults. The number of available studies related to this topic was limited, with significant variability in study design, methods, and outcomes. CONCLUSIONS: This literature review suggests that adolescents with cancer are not treated at optimal settings and are enrolled in clinical trials at low rates. This may lead to inferior treatment and poor subsequent medical and psychosocial outcomes. The scarcity in data further validates the need for additional research focusing on this population.
BACKGROUND: There has been an overall improvement in survival rates for persons with cancer over the past 35 years. However, these gains are less prevalent among adolescents with cancer aged 15 to 19 years, which may be due to lower clinical trial enrollment among adolescents with cancer. METHODS: We conducted a literature review to assess current research regarding clinical trial enrollment and subsequent outcomes among adolescents with cancer. The search included English-language publications that reported original data from January 1985 to October 2011. RESULTS: The search identified 539 records. Of these 539 records, there were 30 relevant original research articles. Multiple studies reported that adolescents with cancer are enrolled in clinical trials at lower rates compared with younger children and older adults. Treatment setting, physician type, and institution type may all be factors in the low enrollment rate among adolescents. Few data focused solely on adolescents, with many studies combining adolescents with young adults. The number of available studies related to this topic was limited, with significant variability in study design, methods, and outcomes. CONCLUSIONS: This literature review suggests that adolescents with cancer are not treated at optimal settings and are enrolled in clinical trials at low rates. This may lead to inferior treatment and poor subsequent medical and psychosocial outcomes. The scarcity in data further validates the need for additional research focusing on this population.
Authors: B Burkhardt; I Oschlies; W Klapper; M Zimmermann; W Woessmann; A Meinhardt; E Landmann; A Attarbaschi; F Niggli; M Schrappe; A Reiter Journal: Leukemia Date: 2010-10-29 Impact factor: 11.528
Authors: Peter H Shaw; Michael Boyiadzis; Hussein Tawbi; Anne Welsh; Aimee Kemerer; Nancy E Davidson; A Kim Ritchey Journal: Cancer Date: 2011-12-27 Impact factor: 6.860
Authors: Mitchell S Cairo; Richard Sposto; Sherrie L Perkins; Anna T Meadows; Margo L Hoover-Regan; James R Anderson; Stuart E Siegel; Mark A Lones; Nicole Tedeschi-Blok; Marshall E Kadin; Carl R Kjeldsberg; John F Wilson; Warren Sanger; Erin Morris; Mark D Krailo; Jonathan L Finlay Journal: Br J Haematol Date: 2003-02 Impact factor: 6.998
Authors: Anne E Kazak; Melissa A Alderfer; Randi Streisand; Steven Simms; Mary T Rourke; Lamia P Barakat; Paul Gallagher; Avital Cnaan Journal: J Fam Psychol Date: 2004-09
Authors: Carla J Berg; Robin C Vanderpool; Betelihem Getachew; Jackelyn B Payne; Meghan F Johnson; Yasmeni Sandridge; Jennifer Bierhoff; Lana Le; Rakiyah Johnson; Amber Weber; Akilah Patterson; Sarah Dorvil; Ann Mertens Journal: J Cancer Educ Date: 2020-12 Impact factor: 2.037
Authors: Michael E Roth; Ann M O'Mara; Nita L Seibel; David S Dickens; Anne-Marie Langevin; Brad H Pollock; David R Freyer Journal: J Oncol Pract Date: 2016-03-29 Impact factor: 3.840
Authors: Kelly D Getz; Tamara P Miller; Alix E Seif; Yimei Li; Yuan-Shung Huang; Todd Alonzo; Robert Gerbing; Lillian Sung; Matthew Hall; Rochelle Bagatell; Alan Gamis; Brian T Fisher; Richard Aplenc Journal: Cancer Med Date: 2016-07-29 Impact factor: 4.452